Prescription RequiredLenvatinib 10 mg (Lentris) is a targeted anticancer medicine used to treat certain types of thyroid cancer, liver cancer, kidney cancer, and endometrial cancer. It belongs to a class of medicines called tyrosine kinase inhibitors (TKIs) and works by blocking proteins involved in tumour growth and the formation of new blood vessels. This helps slow the growth and spread of cancer cells.
| Generic name | Lenvatinib |
| Strength | 10 mg |
| Manufacturer | Mylan Pharmaceuticals |
| Package size | 30 Capsules |
| Used for | Thyroid, liver, kidney, and endometrial cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Lenvatinib is a tyrosine kinase inhibitor (TKI) that blocks several proteins, including VEGF and FGF receptors, which promote tumour growth and the development of new blood vessels. By inhibiting these pathways, it reduces the tumour’s blood supply and slows the growth and spread of cancer cells.
Dr. Neeru Mehta holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. Her interests include cancer treatments, monitoring treatment progress, managing side effects and supportive care.
